IP Verse

Crispr-Based Genome Modification And Regulation - EP3363902B1

PatentPatent Analysis

EP3363902

SIGMA ALDRICH
Application Number
EP18160519A
Filing Date
Dec 5, 2013
Status
Granted And Under Opposition
Oct 25, 2019
Grant Date
Nov 27, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2928496B1
EP3360964B1
EP3138911B1

Bibliography

The patent EP3363902B1 was granted to Sigma Aldrich on Nov 27, 2019 following the initial filing on Dec 5, 2013 under the application number EP18160519A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBAug 27, 2020ADMISSIBLE
SCHLICHAug 27, 2020ADMISSIBLE
BASFAug 25, 2020ADMISSIBLE
PATENT BOUTIQUEMar 2, 2020ADMISSIBLE
GRUNDFeb 4, 2020ADMISSIBLE
BAYER BAYERDec 23, 2019ADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBNov 27, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents